G
Gujarat Themis Biosyn Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 45.02 | 49.81 |
| PB Ratio | 13.22 | 6.38 |
| Dividend Yield | 1.36% | 0.53% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
G
Gujarat Themis Biosyn Ltd
The company makes bulk drugs. It's R&D division focuses on developing fermentation cultures. The Company's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions